Pegi Pavletić, PhD is a postdoctoral fellow at the University of Rijeka, Croatia, under the YUFE4 Postdocs programme, co-funded by MSCA scheme. She has been working as a postdoctoral researcher at the University of Rijeka since 2023. She obtained her PhD in the field of medicinal chemistry, at the University of Camerino, in 2023. Her particular focus was the synthesis and biological evaluation of ligands targeting dopamine receptor D3 and D4, as well as sigma1 receptor. She has experience in organic molecule synthesis, drug-design, drug optimization, molecular modelling and in silico analysis. Prior to her PhD, she studied Research and Development of Drugs at the University of Rijeka, Croatia. Notable academic works: i) https://doi.org/10.1021/acs.jmedchem.2c00840 ii) https://doi.org/10.1016/j.ejmech.2020.113141 iii) https://doi.org/10.1021/acschemneuro.1c00368 iv) https://doi.org/10.1021/acschemneuro.0c00456 Memberships in professional societies: i) Italian Chemical Society (SCI). Divisions: Pharmaceutical Chemistry, Organic Chemistry. Groups: Green Chemistry. ii) American Chemical Society (ACS). Divisions: Biochemistry and Chemical Biology, Medicinal Chemistry, Organic Chemistry. iii) Croatian Chemical Society (HKD). Division: Medicinal and Pharmaceutical Chemistry. iv) International Young Chemists Network (IYCN). v) European Federation of Medicinal Chemistry-Young Scientists Network (EFMC-YSN).